What is the appropriate treatment for group B Streptococcus (Streptococcus agalactiae) isolated from urine?

Treatment of Group B Streptococcus in Urine Culture

All pregnant women with any concentration of GBS isolated from urine must receive immediate treatment of the urinary tract infection followed by mandatory intravenous intrapartum antibiotic prophylaxis during labor, regardless of whether the UTI was treated earlier in pregnancy. 1

Critical Context: Pregnancy Status Determines Management

For Pregnant Women

GBS bacteriuria at any concentration during any trimester is a marker for heavy genital tract colonization and significantly increases the risk of early-onset neonatal GBS disease. 1, 2

Immediate UTI Treatment

• Treat the acute urinary infection immediately according to standard pregnancy UTI protocols using pregnancy-safe antibiotics based on susceptibility testing. 1
• Penicillin G or ampicillin are preferred agents for treating the acute infection. 1, 3
• Treating the UTI during pregnancy does NOT eliminate GBS colonization from the genitourinary tract—recolonization after oral antibiotics is typical. 1

Mandatory Intrapartum Prophylaxis

• All pregnant women with GBS bacteriuria at any point during the current pregnancy must receive intravenous antibiotic prophylaxis during labor, even if the UTI was previously treated. 1, 2
• Penicillin G 5 million units IV initially, then 2.5–3.0 million units IV every 4 hours until delivery is the preferred intrapartum regimen. 1, 2
• Ampicillin 2 g IV initially, then 1 g IV every 4 hours until delivery is an acceptable alternative. 1, 2
• Administer prophylaxis ≥4 hours before delivery for maximum effectiveness—this achieves a 78% reduction in early-onset neonatal GBS disease. 1, 2

For Penicillin-Allergic Pregnant Patients

Risk stratification is essential:

• Low-risk allergy (no history of anaphylaxis, angioedema, respiratory distress, or urticaria): Use cefazolin 2 g IV initially, then 1 g IV every 8 hours until delivery. 1, 3

• High-risk allergy (history of anaphylaxis or severe immediate reactions):

  • Obtain clindamycin and erythromycin susceptibility testing immediately. 1, 3
  • If susceptible to both: Clindamycin 900 mg IV every 8 hours until delivery. 1, 3
  • If resistant or susceptibility unknown: Vancomycin 1 g IV every 12 hours until delivery. 1, 3
  • Perform D-zone testing on isolates that are erythromycin-resistant but clindamycin-susceptible to detect inducible clindamycin resistance. 1, 2

Special Pregnancy Scenarios

• Preterm labor (<37 weeks) with GBS bacteriuria: Initiate GBS prophylaxis immediately upon hospital admission. 1
• Preterm premature rupture of membranes (PPROM): Ampicillin 2 g IV once, followed by 1 g IV every 6 hours for at least 48 hours provides both latency prolongation and GBS prophylaxis. 1
• Women with documented GBS bacteriuria do not require vaginal-rectal screening cultures at 35–37 weeks—they automatically qualify for intrapartum prophylaxis. 1

For Non-Pregnant Adults

The management approach is fundamentally different:

• Do NOT treat asymptomatic bacteriuria in non-pregnant adults, even when GBS is isolated at significant concentrations. 1, 3
• Only treat symptomatic UTI with classic urinary symptoms (dysuria, frequency, urgency, suprapubic pain) or systemic signs of infection (fever, rigors). 1
• For symptomatic UTI: Use standard UTI antibiotics for 7–10 days, with penicillin V 500 mg orally every 6–8 hours as the preferred oral agent. 2
• The single exception: Treat asymptomatic bacteriuria only in patients scheduled for endoscopic urologic procedures involving mucosal trauma. 1

Antibiotic Susceptibility and Resistance Patterns

• All GBS isolates remain universally susceptible to penicillin and beta-lactam antibiotics. 2, 4, 5
• Clindamycin resistance ranges from 3–25% among GBS isolates—susceptibility testing is mandatory before use. 1, 6, 4
• Erythromycin resistance ranges from 7–35%—erythromycin is no longer recommended for prophylaxis or treatment. 1, 7, 6
• Tetracycline resistance is extremely high (96%) and tetracyclines should never be used for GBS. 7
• Vancomycin resistance has not been documented in GBS isolates. 4, 5

Critical Pitfalls to Avoid

• Never treat asymptomatic GBS vaginal or urethral colonization with oral or IV antibiotics before labor in pregnant women—such treatment does not eradicate carriage, promotes resistance, and fails to prevent neonatal disease. 1
• Do not assume that treating the UTI eliminates the need for intrapartum prophylaxis—this is a common and dangerous error. 1
• Never use clindamycin empirically without susceptibility testing in penicillin-allergic patients—resistance rates are too high to justify empiric use. 1, 3
• Do not prescribe nitrofurantoin, fluoroquinolones, sulfonamides, or tetracyclines for GBS infections—they lack proven efficacy. 3
• Underdosing or premature discontinuation of antibiotic treatment leads to treatment failure and recurrence. 3
• Laboratories must report GBS in urine when present at concentrations ≥10,000 CFU/mL (≥10⁴ CFU/mL). 8